The Biotech Growth Trust (LON:BIOG) Announces Quarterly Earnings Results

The Biotech Growth Trust (LON:BIOG) posted its quarterly earnings results on Wednesday. The company reported GBX (1.90) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The Biotech Growth Trust had a net margin of 140.73% and a negative return on equity of 8.91%. The business had revenue of GBX 43 million during the quarter.

The Biotech Growth Trust Price Performance

BIOG opened at GBX 1,246 on Wednesday. The company has a market capitalization of £244.23 million, a price-to-earnings ratio of -87.13 and a beta of 0.59. The firm’s fifty day moving average price is GBX 1,290.02 and its two-hundred day moving average price is GBX 1,248.86. The Biotech Growth Trust has a 1 year low of GBX 701.63 and a 1 year high of GBX 1,374.

About The Biotech Growth Trust

The Biotech Growth Trust seeks capital appreciation through investment in the worldwide biotechnology industry. In order to achieve its investment objective, the Company invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. Performance is measured against the NASDAQ Biotechnology Index (sterling adjusted).